CONGENITAL RETINOBLASTOMA

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting CONGENITAL RETINOBLASTOMA:

# Drug Count
0 CARBOPLATIN 6
1 ETOPOSIDE 6
2 LARONIDASE 3
3 ZIDOVUDINE 3
4 LAMIVUDINE AND ZIDOVUDINE 2
5 MELPHALAN 2
6 MELPHALAN HYDROCHLORIDE 2
7 TOPOTECAN 2
8 FINGOLIMOD HCL 1
9 FOLIC ACID 1
See all common drugs associated with CONGENITAL RETINOBLASTOMA

CONGENITAL RETINOBLASTOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LARONIDASE 3 0.0007
1 TOPOTECAN 2 0.0003
2 ZIDOVUDINE 3 0.0003
3 LAMIVUDINE AND ZIDOVUDINE 2 0.0003
4 ETOPOSIDE 6 0.0001
5 MELPHALAN HYDROCHLORIDE 2 0.0001
6 CARBOPLATIN 6 0.0000
7 FINGOLIMOD HCL 1 0.0000
8 INTERFERON BETA-1A 1 0.0000
9 FOLIC ACID 1 0.0000
See all drugs enriched for association with CONGENITAL RETINOBLASTOMA